Interleukin-10	B-protein
and	O
transforming	B-DNA
growth	I-DNA
factor-beta	I-DNA
promoter	I-DNA
polymorphisms	I-DNA
in	O
allergies	O
and	O
asthma	O
.	O

Interleukin-10	B-protein
(	O
IL-10	B-protein
)	O
and	O
transforming	B-protein
growth	I-protein
factor	I-protein
beta	I-protein
(	O
TGF-beta	B-protein
)	O
are	O
inhibitory	O
for	O
B	B-cell_type
and	I-cell_type
T	I-cell_type
cells	I-cell_type
,	O
IgE	B-protein
production	O
,	O
and	O
mast	O
cell	O
proliferation	O
,	O
and	O
they	O
induce	O
apoptosis	O
in	O
eosinophils	B-cell_type
.	O

These	O
cytokines	B-protein
are	O
therefore	O
candidate	O
genes	O
which	O
could	O
contribute	O
to	O
the	O
development	O
of	O
asthma	O
or	O
allergies	O
.	O

We	O
investigated	O
the	O
hypothesis	O
that	O
polymorphic	O
nucleotides	O
within	O
the	O
IL-10	B-DNA
and	I-DNA
TGF-beta	I-DNA
gene	I-DNA
promoters	I-DNA
would	O
link	O
to	O
the	O
expression	O
of	O
allergies	O
and	O
asthma	O
.	O

DNA	O
taken	O
from	O
families	O
with	O
an	O
asthmatic	O
proband	O
was	O
examined	O
for	O
base	O
exchanges	O
by	O
single-stranded	O
conformational	O
polymorphism	O
(	O
SSCP	O
)	O
.	O

We	O
demonstrated	O
the	O
presence	O
of	O
a	O
polymorphism	O
in	O
the	O
promoter	B-DNA
region	I-DNA
of	O
the	O
IL-10	B-DNA
gene	I-DNA
and	O
four	O
in	O
the	O
TGF-beta	B-DNA
gene	I-DNA
promoters	I-DNA
(	O
3	O
in	O
TGF-beta1	B-DNA
and	O
1	O
in	O
TGF-beta2	B-DNA
)	O
.	O

The	O
IL-10	B-protein
gene	O
polymorphism	O
was	O
a	O
C-to-A	O
exchange	O
571	B-DNA
base	I-DNA
pairs	I-DNA
upstream	I-DNA
from	O
the	O
translation	B-DNA
start	I-DNA
site	I-DNA
and	O
was	O
present	O
between	O
consensus	B-DNA
binding	I-DNA
sequences	I-DNA
for	O
Sp1	B-protein
and	O
elevated	O
total	O
serum	O
.	O

This	O
polymorphism	O
was	O
associated	O
with	O
elevated	O
total	B-protein
serum	I-protein
IgE	I-protein
in	O
subjects	O
heterozygotic	O
or	O
homozygotic	O
for	O
this	O
base	O
exchange	O
(	O
p	O
<	O
0.009	O
)	O
.	O

The	O
base	O
exchange	O
at	O
-509	O
(	O
from	O
the	O
transcription	O
initiation	O
site	O
)	O
in	O
the	O
TGF-beta	B-DNA
promoter	I-DNA
also	O
linked	O
to	O
elevated	O
total	O
IgE	B-protein
(	O
p	O
<	O
0.01	O
)	O
.	O

This	O
polymorphism	O
represented	O
a	O
C-to-T	O
base	O
exchange	O
which	O
induced	O
a	O
YY1	B-DNA
consensus	I-DNA
sequence	I-DNA
and	O
is	O
present	O
in	O
a	O
region	O
of	O
the	O
promoter	O
associated	O
with	O
negative	O
transcription	O
regulation	O
.	O

Interleukin-10	NULL
and	NULL
Transforming	NULL
Growth	NULL
Factor-B	NULL
Promoter	NULL
Polymorphisms	NULL
in	NULL
Allergies	NULL
and	NULL
Asthma	NULL
KATHRYN	NULL
HOBBS	NULL
,	NULL
JULIE	NULL
NEGRI	NULL
,	NULL
MARY	NULL
KLINNERT	NULL
,	NULL
LANNY	NULL
J	NULL
ROSENWASSER	NULL
,	NULL
and	NULL
LARRY	NULL
BORISH	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Pediatrics	NULL
,	NULL
National	NULL
Jewish	NULL
Medical	NULL
and	NULL
Research	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
Colorado	NULL
Health	NULL
Sciences	NULL
Center	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
Interleukin-10	NULL
(	NULL
IL-10	NULL
)	NULL
and	NULL
transforming	NULL
growth	NULL
factor	NULL
beta	NULL
(	NULL
TGF-	NULL
)	NULL
are	NULL
inhibitory	NULL
for	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
IgE	NULL
production	NULL
,	NULL
and	NULL
mast	NULL
cell	NULL
proliferation	NULL
,	NULL
and	NULL
they	NULL
induce	NULL
apoptosis	NULL
in	NULL
eosinophils	NULL
.	NULL

These	NULL
cytokines	NULL
are	NULL
therefore	NULL
candidate	NULL
genes	NULL
which	NULL
could	NULL
contribute	NULL
to	NULL
the	NULL
development	NULL
of	NULL
asthma	NULL
or	NULL
allergies	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
hypothesis	NULL
that	NULL
polymorphic	NULL
nucleotides	NULL
within	NULL
the	NULL
IL-10	NULL
and	NULL
TGF-B	NULL
gene	NULL
promoters	NULL
would	NULL
link	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
allergies	NULL
and	NULL
asthma	NULL
.	NULL

DNA	NULL
taken	NULL
from	NULL
families	NULL
with	NULL
an	NULL
asthmatic	NULL
proband	NULL
was	NULL
examined	NULL
for	NULL
base	NULL
exchanges	NULL
by	NULL
single-stranded	NULL
conformational	NULL
polymorphism	NULL
(	NULL
SSCP	NULL
)	NULL
.	NULL

We	NULL
demonstrated	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
polymorphism	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
IL-10	NULL
gene	NULL
and	NULL
four	NULL
in	NULL
the	NULL
gene	NULL
promoters	NULL
(	NULL
3	NULL
in	NULL
TGF-81	NULL
and	NULL
1	NULL
in	NULL
TGF-82	NULL
)	NULL
.	NULL

The	NULL
IL-10	NULL
gene	NULL
polymorphism	NULL
was	NULL
a	NULL
C-to-A	NULL
exchange	NULL
571	NULL
base	NULL
pairs	NULL
upstream	NULL
from	NULL
the	NULL
translation	NULL
start	NULL
site	NULL
and	NULL
was	NULL
present	NULL
between	NULL
consensus	NULL
binding	NULL
sequences	NULL
for	NULL
Sp1	NULL
and	NULL
elevated	NULL
total	NULL
serum	NULL
.	NULL

This	NULL
polymorphism	NULL
was	NULL
associated	NULL
with	NULL
elevated	NULL
total	NULL
serum	NULL
IgE	NULL
in	NULL
subjects	NULL
heterozygotic	NULL
or	NULL
homozygotic	NULL
for	NULL
this	NULL
base	NULL
exchange	NULL
(	NULL
p	NULL
<	NULL
0.009	NULL
)	NULL
.	NULL

The	NULL
base	NULL
exchange	NULL
at	NULL
509	NULL
(	NULL
from	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
)	NULL
in	NULL
the	NULL
TGF-	NULL
promoter	NULL
also	NULL
linked	NULL
to	NULL
elevated	NULL
total	NULL
IgE	NULL
(	NULL
p	NULL
<	NULL
0.01	NULL
)	NULL
.	NULL

This	NULL
polymorphism	NULL
represented	NULL
a	NULL
C-to-T	NULL
base	NULL
exchange	NULL
which	NULL
induced	NULL
a	NULL
YY1	NULL
consensus	NULL
sequence	NULL
and	NULL
is	NULL
present	NULL
in	NULL
a	NULL
region	NULL
of	NULL
the	NULL
promoter	NULL
associated	NULL
with	NULL
negative	NULL
transcription	NULL
regulation	NULL
.	NULL

Hobbs	NULL
K	NULL
,	NULL
Negri	NULL
J	NULL
Klinnert	NULL
M	NULL
,	NULL
Rosenwasser	NULL
LJ	NULL
Borish	NULL
L	NULL
Interleukin-10	NULL
and	NULL
transforming	NULL
frowth	NULL
factor-8	NULL
promoter	NULL
polymorphisms	NULL
in	NULL
allergies	NULL
and	NULL
asthma	NULL
.	NULL

AM	NULL
JRESPIR	NULL
CRIT	NULL
CARE	NULL
MED	NULL
1998	NULL
;	NULL
158:1958-1962	NULL
.	NULL

Interleukin-10	NULL
(	NULL
IL-10	NULL
)	NULL
and	NULL
transforming	NULL
growth	NULL
factor	NULL
beta	NULL
(	NULL
TGF-B	NULL
)	NULL
are	NULL
anti-inflammatory	NULL
cytokines	NULL
that	NULL
are	NULL
constitutively	NULL
expressed	NULL
in	NULL
the	NULL
healthy	NULL
airway	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

Both	NULL
IL-10	NULL
and	NULL
TGF-B	NULL
downregulate	NULL
cellular	NULL
immunity	NULL
and	NULL
allergic	NULL
inflam-mation	NULL
.	NULL

Diminished	NULL
secretion	NULL
of	NULL
these	NULL
cytokines	NULL
could	NULL
contribute	NULL
to	NULL
the	NULL
development	NULL
of	NULL
a	NULL
milieu	NULL
in	NULL
which	NULL
allergic	NULL
inflammation	NULL
and	NULL
asthma	NULL
can	NULL
develop	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
their	NULL
anti-inflammatory	NULL
effects	NULL
,	NULL
the	NULL
appearance	NULL
of	NULL
IL-10	NULL
and	NULL
TGF-B	NULL
in	NULL
ongoing	NULL
allergic	NULL
inflammation	NULL
may	NULL
contribute	NULL
to	NULL
disease	NULL
severity	NULL
by	NULL
stimulating	NULL
IgE	NULL
synthesis	NULL
(	NULL
5	NULL
)	NULL
and	NULL
fibrosis	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Polymorphisms	NULL
in	NULL
promoter	NULL
sequences	NULL
of	NULL
genes	NULL
result	NULL
in	NULL
abnormal	NULL
transcriptional	NULL
regulation	NULL
and	NULL
thereby	NULL
influence	NULL
the	NULL
development	NULL
or	NULL
severity	NULL
of	NULL
disease	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
presence	NULL
and	NULL
linkage	NULL
of	NULL
polymorphic	NULL
nucleotides	NULL
within	NULL
the	NULL
IL-10	NULL
and	NULL
TGF-	NULL
gene	NULL
promoters	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
allergic	NULL
and	NULL
asthmatic	NULL
phenotype	NULL
.	NULL

We	NULL
detected	NULL
base	NULL
substitutions	NULL
as	NULL
single-stranded	NULL
conformational	NULL
polymorphisms	NULL
(	NULL
SSCPs	NULL
)	NULL
.	NULL

We	NULL
screened	NULL
each	NULL
polymorphism	NULL
by	NULL
case-control	NULL
analysis	NULL
for	NULL
linkage	NULL
to	NULL
al	NULL
(	NULL
Received	NULL
in	NULL
original	NULL
form	NULL
April	NULL
2	NULL
,	NULL
1998	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
Lily	NULL
27	NULL
,	NULL
1998	NULL
)	NULL
Supported	NULL
by	NULL
GCRC	NULL
MO1	NULL
RADOOS1	NULL
,	NULL
The	NULL
American	NULL
Lung	NULL
Association	NULL
.	NULL

Dr.	NULL
Hobbs	NULL
is	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
President	NULL
's	NULL
Grant-in-Aid	NULL
Award	NULL
from	NULL
the	NULL
American	NULL
Academy	NULL
of	NULL
Allergy	NULL
,	NULL
Asthma	NULL
,	NULL
and	NULL
Immunology	NULL
.	NULL

Correspondence	NULL
and	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
to	NULL
Kathryn	NULL
Hobbs	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
Division	NULL
of	NULL
Rheumatology	NULL
,	NULL
University	NULL
of	NULL
Colorado	NULL
Health	NULL
Sciences	NULL
Center	NULL
,	NULL
4701	NULL
East	NULL
Ninth	NULL
Ave.	NULL
,	NULL
Denver	NULL
,	NULL
CO	NULL
80206	NULL
.	NULL

Am	NULL
JRespir	NULL
Crit	NULL
Care	NULL
Med	NULL
Vol	NULL
158.	NULL
pp	NULL
1958-1962	NULL
,	NULL
1998	NULL
Internet	NULL
address	NULL
:	NULL
www.atsjiournals.org	NULL
lergy	NULL
and	NULL
asthma	NULL
phenotypes	NULL
using	NULL
our	NULL
data	NULL
base	NULL
containing	NULL
20	NULL
atopic	NULL
asthmatic	NULL
and	NULL
10	NULL
nonasthmatic	NULL
families	NULL
.	NULL

METHODS	NULL
Subjects	NULL
Subjects	NULL
were	NULL
recruited	NULL
from	NULL
the	NULL
asthma	NULL
risk	NULL
study	NULL
which	NULL
has	NULL
been	NULL
performed	NULL
at	NULL
the	NULL
National	NULL
Jewish	NULL
Medical	NULL
and	NULL
Research	NULL
Center	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

These	NULL
families	NULL
were	NULL
identified	NULL
from	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
pregnant	NULL
mother	NULL
with	NULL
asthma	NULL
,	NULL
and	NULL
the	NULL
proband	NULL
is	NULL
the	NULL
child	NULL
who	NULL
has	NULL
been	NULL
followed	NULL
since	NULL
birth	NULL
(	NULL
ages	NULL
5	NULL
to	NULL
10	NULL
at	NULL
the	NULL
time	NULL
these	NULL
studies	NULL
were	NULL
per-formed	NULL
)	NULL
.	NULL

These	NULL
were	NULL
all	NULL
nuclear	NULL
families	NULL
in	NULL
which	NULL
we	NULL
studied	NULL
both	NULL
par-ents	NULL
,	NULL
the	NULL
proband	NULL
,	NULL
and	NULL
siblings	NULL
.	NULL

The	NULL
number	NULL
of	NULL
siblings	NULL
ranged	NULL
from	NULL
1	NULL
to	NULL
4	NULL
,	NULL
although	NULL
we	NULL
selected	NULL
for	NULL
larger	NULL
families	NULL
and	NULL
most	NULL
had	NULL
2	NULL
to	NULL
3	NULL
siblings	NULL
.	NULL

Our	NULL
phenotyping	NULL
studies	NULL
involved	NULL
the	NULL
clinical	NULL
diagnosis	NULL
of	NULL
allergic	NULL
rhinitis	NULL
or	NULL
asthma	NULL
based	NULL
on	NULL
medical	NULL
history	NULL
and	NULL
physical	NULL
examina-tion	NULL
.	NULL

Objective	NULL
parameters	NULL
included	NULL
performing	NULL
pulmonary	NULL
function	NULL
tests	NULL
before	NULL
and	NULL
after	NULL
administration	NULL
of	NULL
a	NULL
bronchodilator	NULL
,	NULL
methacholine	NULL
challenges	NULL
,	NULL
skin	NULL
testing	NULL
to	NULL
the	NULL
Colorado	NULL
allergen	NULL
panel	NULL
,	NULL
and	NULL
obtaining	NULL
blood	NULL
specimens	NULL
for	NULL
total	NULL
IgE	NULL
and	NULL
total	NULL
eosinophil	NULL
counts	NULL
.	NULL

Specific	NULL
parameters	NULL
which	NULL
we	NULL
analyzed	NULL
for	NULL
these	NULL
studies	NULL
included	NULL
:	NULL
baseline	NULL
percent	NULL
predicted	NULL
FEV	NULL
;	NULL
,	NULL
percent	NULL
reversibility	NULL
of	NULL
the	NULL
FEV	NULL
;	NULL
after	NULL
administration	NULL
of	NULL
albuterol	NULL
,	NULL
log	NULL
concentration	NULL
of	NULL
methacholine	NULL
producing	NULL
20	NULL
%	NULL
reduction	NULL
in	NULL
the	NULL
FEV	NULL
;	NULL
(	NULL
PD	NULL
;	NULL
,	NULL
)	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
any	NULL
positive	NULL
prick	NULL
skin	NULL
test	NULL
,	NULL
the	NULL
number	NULL
of	NULL
positive	NULL
skin	NULL
tests	NULL
,	NULL
total	NULL
IgE	NULL
,	NULL
and	NULL
eosinophil	NULL
count	NULL
.	NULL

Twenty	NULL
of	NULL
these	NULL
families	NULL
were	NULL
phenotyped	NULL
and	NULL
underwent	NULL
phlebotomy	NULL
for	NULL
DNA	NULL
extraction	NULL
using	NULL
a	NULL
commercial	NULL
DNA	NULL
extraction	NULL
kit	NULL
(	NULL
Gentra	NULL
Systems	NULL
,	NULL
Inc.	NULL
,	NULL
Research	NULL
Triangle	NULL
Park	NULL
,	NULL
NC	NULL
)	NULL
.	NULL

An	NULL
additional	NULL
10	NULL
families	NULL
were	NULL
recruited	NULL
in	NULL
whom	NULL
no	NULL
family	NULL
member	NULL
had	NULL
cither	NULL
allergies	NULL
or	NULL
asthma	NULL
.	NULL

All	NULL
patients	NULL
including	NULL
children	NULL
provided	NULL
their	NULL
informed	NULL
consent	NULL
for	NULL
this	NULL
study	NULL
and	NULL
the	NULL
protocol	NULL
was	NULL
ap-	NULL
Hobbs	NULL
,	NULL
Negri	NULL
,	NULL
Klinnert	NULL
,	NULL
ef	NULL
a/	NULL
.	NULL

:	NULL
Gene	NULL
Polymorphisms	NULL
in	NULL
Allergies	NULL
and	NULL
Asthma	NULL
proved	NULL
by	NULL
the	NULL
investigational	NULL
review	NULL
boards	NULL
of	NULL
the	NULL
National	NULL
Jewish	NULL
Medical	NULL
and	NULL
Research	NULL
Center	NULL
and	NULL
the	NULL
University	NULL
of	NULL
Colorado	NULL
Health	NULL
Sciences	NULL
Center	NULL
.	NULL

Single-Stranded	NULL
Conformational	NULL
Polymorphisms	NULL
(	NULL
SSCP	NULL
)	NULL
The	NULL
SSCP	NULL
technology	NULL
takes	NULL
advantage	NULL
of	NULL
the	NULL
different	NULL
secondary	NULL
structure	NULL
and	NULL
therefore	NULL
electrophoretic	NULL
mobility	NULL
induced	NULL
in	NULL
single-stranded	NULL
DNA	NULL
by	NULL
a	NULL
substitution	NULL
in	NULL
as	NULL
few	NULL
as	NULL
a	NULL
single	NULL
nucleotide	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

SSCP	NULL
was	NULL
performed	NULL
on	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
of	NULL
IL-10	NULL
,	NULL
TGF-B1	NULL
,	NULL
TGF-B2	NULL
,	NULL
and	NULL
TGF-B3	NULL
.	NULL

Our	NULL
approach	NULL
was	NULL
to	NULL
investigate	NULL
the	NULL
first	NULL
1	NULL
kB	NULL
5	NULL
'	NULL
from	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
TIS	NULL
)	NULL
as	NULL
most	NULL
base	NULL
substitutions	NULL
likely	NULL
to	NULL
have	NULL
important	NULL
effects	NULL
on	NULL
transcriptional	NULL
regulation	NULL
would	NULL
be	NULL
expected	NULL
to	NULL
lie	NULL
within	NULL
this	NULL
region	NULL
.	NULL

Promoter/enhancer	NULL
sequences	NULL
were	NULL
analyzed	NULL
in	NULL
fragments	NULL
cach	NULL
~	NULL
250	NULL
bp	NULL
in	NULL
length	NULL
,	NULL
using	NULL
primer	NULL
sequences	NULL
synthesized	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
381A	NULL
DNA	NULL
synthesizer	NULL
(	NULL
Albany	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

To	NULL
perform	NULL
the	NULL
SSCP	NULL
analyses	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
was	NULL
performed	NULL
on	NULL
genomic	NULL
DNA	NULL
(	NULL
1	NULL
jg	NULL
)	NULL
and	NULL
internally	NULL
labeled	NULL
with	NULL
[	NULL
Pa	NULL
]	NULL
P-dATP	NULL
.	NULL

PCR	NULL
product	NULL
was	NULL
diluted	NULL
in	NULL
0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SD	NULL
S	NULL
)	NULL
/10	NULL
mM	NULL
ethylene	NULL
diaminetetraacetic	NULL
acid	NULL
(	NULL
EDTA	NULL
)	NULL
and	NULL
mixed	NULL
with	NULL
formamide	NULL
dye	NULL
(	NULL
95	NULL
%	NULL
)	NULL
.	NULL

The	NULL
double-stranded	NULL
DNA	NULL
(	NULL
dsDNA	NULL
)	NULL
was	NULL
denatured	NULL
at	NULL
95°	NULL
C	NULL
for	NULL
5	NULL
min	NULL
,	NULL
rapidly	NULL
chilled	NULL
,	NULL
and	NULL
the	NULL
denatured	NULL
DNA	NULL
was	NULL
loaded	NULL
on	NULL
a	NULL
4.5	NULL
%	NULL
nondenaturing	NULL
acrylamide	NULL
gel	NULL
under	NULL
four	NULL
conditions	NULL
:	NULL
4°	NULL
C	NULL
and	NULL
22°	NULL
C	NULL
with	NULL
and	NULL
without	NULL
5	NULL
%	NULL
glycerol	NULL
.	NULL

Electrophoresis	NULL
was	NULL
performed	NULL
with	NULL
constant	NULL
monitoring	NULL
of	NULL
temperature	NULL
to	NULL
minimize	NULL
heating	NULL
during	NULL
the	NULL
electrophoresis	NULL
.	NULL

After	NULL
electrophoresis	NULL
was	NULL
completed	NULL
,	NULL
the	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
autoradiography	NULL
per-formed	NULL
.	NULL

Heteroduplex	NULL
Analysis	NULL
The	NULL
four	NULL
combinations	NULL
of	NULL
conditions	NULL
under	NULL
which	NULL
SSCP	NULL
is	NULL
performed	NULL
will	NULL
detect	NULL
~	NULL
80	NULL
to	NULL
90	NULL
%	NULL
of	NULL
all	NULL
contained	NULL
mutations	NULL
.	NULL

This	NULL
can	NULL
be	NULL
improved	NULL
to	NULL
virtually	NULL
100	NULL
%	NULL
through	NULL
the	NULL
additional	NULL
analysis	NULL
of	NULL
PCR	NULL
products	NULL
via	NULL
heteroduplex	NULL
analysis	NULL
of	NULL
double-stranded	NULL
molecules	NULL
(	NULL
10	NULL
)	NULL
.	NULL

This	NULL
is	NULL
based	NULL
on	NULL
the	NULL
concept	NULL
that	NULL
when	NULL
PCR	NULL
is	NULL
performed	NULL
on	NULL
two	NULL
alleles	NULL
,	NULL
during	NULL
the	NULL
denaturing	NULL
and	NULL
reanncaling	NULL
process	NULL
dsDNA	NULL
is	NULL
formed	NULL
from	NULL
both	NULL
identical	NULL
complementary	NULL
strands	NULL
(	NULL
homoduplexes	NULL
)	NULL
but	NULL
also	NULL
from	NULL
the	NULL
annealing	NULL
of	NULL
complementary	NULL
strands	NULL
from	NULL
the	NULL
two	NULL
different	NULL
amplified	NULL
segments	NULL
(	NULL
heteroduplexes	NULL
)	NULL
.	NULL

These	NULL
heteroduplexes	NULL
may	NULL
be	NULL
detected	NULL
as	NULL
a	NULL
mobility	NULL
shift	NULL
using	NULL
the	NULL
same	NULL
acrylamide	NULL
electrophoresis	NULL
as	NULL
performed	NULL
for	NULL
the	NULL
SSCP	NULL
.	NULL

DNA	NULL
Sequencing	NULL
of	NULL
Polymorphic	NULL
Regions	NULL
Polymorphic	NULL
DNA	NULL
was	NULL
extracted	NULL
from	NULL
the	NULL
acrylamide	NULL
,	NULL
PCR-ampli-fied	NULL
using	NULL
the	NULL
original	NULL
primers	NULL
used	NULL
in	NULL
the	NULL
SSCP	NULL
analysis	NULL
,	NULL
and	NULL
purified	NULL
from	NULL
agarose	NULL
(	NULL
Qiagen	NULL
,	NULL
Inc.	NULL
,	NULL
Valencia	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Automated	NULL
DNA	NULL
sequencing	NULL
was	NULL
performed	NULL
using	NULL
fluorescent	NULL
dideoxy	NULL
sequence	NULL
terminators	NULL
(	NULL
Applied	NULL
Biosystems	NULL
)	NULL
.	NULL

Primers	NULL
internally	NULL
nested	NULL
from	NULL
those	NULL
used	NULL
for	NULL
the	NULL
SSCP	NULL
were	NULL
synthesized	NULL
.	NULL

Sequencing	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
both	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
directions	NULL
both	NULL
to	NULL
provide	NULL
corroborative	NULL
data	NULL
and	NULL
to	NULL
read	NULL
potentially	NULL
poorly	NULL
discernible	NULL
areas	NULL
on	NULL
the	NULL
sequencer	NULL
readout	NULL
.	NULL

Base	NULL
exchanges	NULL
were	NULL
characterized	NULL
by	NULL
Pustell	NULL
matrix	NULL
analysis	NULL
performed	NULL
with	NULL
MacVector	NULL
software	NULL
.	NULL

Association	NULL
Studies	NULL
We	NULL
performed	NULL
association	NULL
analyses	NULL
to	NULL
determine	NULL
influences	NULL
of	NULL
the	NULL
polymorphisms	NULL
on	NULL
phenotype	NULL
.	NULL

Association	NULL
studies	NULL
can	NULL
not	NULL
be	NULL
performed	NULL
on	NULL
related	NULL
family	NULL
members	NULL
.	NULL

While	NULL
we	NULL
screened	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
polymorphisms	NULL
in	NULL
144	NULL
related	NULL
individuals	NULL
derived	NULL
from	NULL
30	NULL
families	NULL
,	NULL
these	NULL
association	NULL
studies	NULL
were	NULL
only	NULL
performed	NULL
on	NULL
the	NULL
30	NULL
unrelated	NULL
probands	NULL
from	NULL
cach	NULL
family	NULL
and	NULL
17	NULL
additional	NULL
probands	NULL
with	NULL
and	NULL
without	NULL
asthma	NULL
recruited	NULL
from	NULL
the	NULL
asthma	NULL
risk	NULL
study	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
a	NULL
significant	NULL
linkage	NULL
to	NULL
asthma/allergy	NULL
phenotype	NULL
supports	NULL
the	NULL
hypothesis	NULL
that	NULL
these	NULL
mutations	NULL
influence	NULL
the	NULL
risk	NULL
for	NULL
developing	NULL
these	NULL
conditions	NULL
.	NULL

Association	NULL
studies	NULL
compare	NULL
random	NULL
samples	NULL
of	NULL
unrelated	NULL
subjects	NULL
and	NULL
controls	NULL
to	NULL
assess	NULL
the	NULL
relative	NULL
frequencies	NULL
at	NULL
which	NULL
a	NULL
given	NULL
allele	NULL
appears	NULL
in	NULL
these	NULL
two	NULL
populations	NULL
.	NULL

This	NULL
is	NULL
the	NULL
most	NULL
sensitive	NULL
indicator	NULL
of	NULL
genetic	NULL
linkages	NULL
and	NULL
can	NULL
generate	NULL
significant	NULL
data	NULL
with	NULL
fewer	NULL
individuals	NULL
.	NULL

For	NULL
parametric	NULL
data	NULL
with	NULL
normal	NULL
distribution	NULL
(	NULL
including	NULL
FEV	NULL
,	NULL
,	NULL
FEV	NULL
,	NULL
/FVC	NULL
ratio	NULL
,	NULL
percent	NULL
change	NULL
in	NULL
FEV	NULL
;	NULL
after	NULL
administration	NULL
of	NULL
bronchodilator	NULL
,	NULL
and	NULL
total	NULL
eosinophil	NULL
count	NULL
)	NULL
,	NULL
statistical	NULL
analyses	NULL
were	NULL
performed	NULL
using	NULL
analysis	NULL
of	NULL
variance	NULL
(	NULL
ANOVA	NULL
)	NULL
.	NULL

1959	NULL
For	NULL
the	NULL
statistical	NULL
analysis	NULL
of	NULL
total	NULL
serum	NULL
IgE	NULL
,	NULL
data	NULL
were	NULL
first	NULL
converted	NULL
to	NULL
log	NULL
IgE	NULL
to	NULL
produce	NULL
a	NULL
normal	NULL
distribution	NULL
and	NULL
then	NULL
analyzed	NULL
via	NULL
ANOVA	NULL
.	NULL

For	NULL
nonparametric	NULL
data	NULL
(	NULL
presence	NULL
of	NULL
an	NULL
atopic	NULL
discase	NULL
,	NULL
clinical	NULL
diagnosis	NULL
of	NULL
asthma	NULL
,	NULL
presence	NULL
of	NULL
positive	NULL
skin	NULL
tests	NULL
)	NULL
and	NULL
for	NULL
parametric	NULL
data	NULL
with	NULL
a	NULL
non-normal	NULL
distribution	NULL
(	NULL
PD	NULL
;	NULL
,	NULL
)	NULL
statistical	NULL
analyses	NULL
were	NULL
performed	NULL
utilizing	NULL
chi-square	NULL
analyses	NULL
.	NULL

These	NULL
studies	NULL
were	NULL
performed	NULL
to	NULL
demonstrate	NULL
the	NULL
disproportional	NULL
presence	NULL
of	NULL
a	NULL
given	NULL
allele	NULL
in	NULL
affected	NULL
individuals	NULL
.	NULL

Statistics	NULL
were	NULL
performed	NULL
on	NULL
a	NULL
Macintosh	NULL
computer	NULL
using	NULL
JMP	NULL
3.1	NULL
software	NULL
.	NULL

RESULTS	NULL
SSCP	NULL
Our	NULL
laboratory	NULL
cloned	NULL
and	NULL
sequenced	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
IL-10	NULL
gene	NULL
to	NULL
assess	NULL
the	NULL
role	NULL
of	NULL
its	NULL
promoter	NULL
in	NULL
the	NULL
development	NULL
of	NULL
human	NULL
allergic	NULL
diseases	NULL
.	NULL

Our	NULL
approach	NULL
to	NULL
sequencing	NULL
the	NULL
IL-10	NULL
promoter	NULL
exploited	NULL
the	NULL
human	NULL
IL-10	NULL
comple-	NULL
Interleukin-10	NULL
dw	NULL
#	NULL
¢	NULL
v*	NULL
-	NULL
-=	NULL
>	NULL
a	NULL
b	NULL
c	NULL
d	NULL
oe	NULL
-	NULL
f	NULL
Figure	NULL
1	NULL
.	NULL

Single-stranded	NULL
conformational	NULL
polymorphisms	NULL
.	NULL

Genomic	NULL
DNA	NULL
underwent	NULL
PCR	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
primers	NULL
specific	NULL
for	NULL
approximately	NULL
250	NULL
base	NULL
pairs	NULL
of	NULL
the	NULL
IL-10	NULL
or	NULL
TGF-	NULL
promoters	NULL
,	NULL
in	NULL
the	NULL
additional	NULL
presence	NULL
of	NULL
The	NULL
dsDNA	NULL
was	NULL
heat-denatured	NULL
and	NULL
electrophoresed	NULL
on	NULL
a	NULL
4.5	NULL
%	NULL
nondenaturing	NULL
acrylamide	NULL
gel	NULL
at	NULL
22°	NULL
C	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
5	NULL
%	NULL
glycerol	NULL
.	NULL

(	NULL
Upper	NULL
panel	NULL
)	NULL
SSCP	NULL
for	NULL
the	NULL
IL-10	NULL
promoter	NULL
.	NULL

One	NULL
family	NULL
is	NULL
shown	NULL
with	NULL
one	NULL
parent	NULL
homozygous	NULL
wild	NULL
type	NULL
(	NULL
/ane	NULL
a	NULL
)	NULL
,	NULL
one	NULL
parent	NULL
homozygous	NULL
for	NULL
the	NULL
base	NULL
exchange	NULL
(	NULL
lane	NULL
d	NULL
)	NULL
,	NULL
and	NULL
the	NULL
two	NULL
heterozygotic	NULL
children	NULL
(	NULL
anes	NULL
b	NULL
and	NULL
c	NULL
)	NULL
.	NULL

(	NULL
Lower	NULL
panel	NULL
)	NULL
SSCP	NULL
for	NULL
the	NULL
TGF-B1	NULL
promoter	NULL
.	NULL

Unrelated	NULL
subjects	NULL
are	NULL
displayed	NULL
who	NULL
demonstrated	NULL
the	NULL
patterns	NULL
for	NULL
homozygote	NULL
wild	NULL
type	NULL
(	NULL
Jane	NULL
a	NULL
)	NULL
,	NULL
heterozygotes	NULL
(	NULL
lanes	NULL
b-e	NULL
)	NULL
,	NULL
and	NULL
homozygotic	NULL
for	NULL
the	NULL
base	NULL
exchange	NULL
(	NULL
Jane	NULL
f	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
pattern	NULL
observed	NULL
for	NULL
IL-10	NULL
,	NULL
the	NULL
base	NULL
exchange	NULL
in	NULL
the	NULL
complementary	NULL
strand	NULL
of	NULL
DNA	NULL
does	NULL
not	NULL
produce	NULL
a	NULL
conformational	NULL
change	NULL
sufficient	NULL
to	NULL
produce	NULL
a	NULL
motility	NULL
shift	NULL
.	NULL

1960	NULL
Interleukin-10	NULL
Promoter	NULL
Polymorphism	NULL
:	NULL
TGTGA	NULL
|CCCCGCC	NULL
|	NULL
TGT	NULL
'|TGTAGGAAG	NULL
|	NULL
CCA	NULL
ACACT	NULL
|GGGGCGG	NULL
]	NULL
|	NULL
aca	NULL
l	NULL
G|ACATCCTTC	NULL
|	NULL
GGT	NULL
-586	NULL
“	NULL
I	NULL
558	NULL
-	NULL
from	NULL
the	NULL
translation	NULL
start	NULL
site	NULL
Transforming	NULL
Growth	NULL
Factor-Bl	NULL
Promoter	NULL
Polymorphism	NULL
:	NULL
TGACC	NULL
{	NULL
CTTCCATCC	NULL
Er	NULL
.	NULL

TCAGG	NULL
|	NULL
TGTCCT	NULL
ACTGG	NULL
|GAAGGTAGG	NULL
G	NULL
AGTCC	NULL
|	NULL
ACAGGA	NULL
523	NULL
oe	NULL
-498	NULL
Figure	NULL
2	NULL
.	NULL

Sequence	NULL
of	NULL
the	NULL
IL-10	NULL
and	NULL
TGF-B1	NULL
polymorphisms	NULL
.	NULL

Wild-type	NULL
and	NULL
base	NULL
exchange	NULL
sequences	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
IL-10	NULL
polymorphism	NULL
is	NULL
present	NULL
at	NULL
bp	NULL
~571	NULL
from	NULL
the	NULL
open	NULL
reading	NULL
frame	NULL
and	NULL
represents	NULL
a	NULL
C-to-A	NULL
exchange	NULL
.	NULL

It	NULL
is	NULL
present	NULL
between	NULL
consensus	NULL
sequences	NULL
for	NULL
So1	NULL
binding	NULL
and	NULL
binding	NULL
by	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
.	NULL

The	NULL
TGF-8B1	NULL
polymorphism	NULL
is	NULL
present	NULL
at	NULL
bp	NULL
~509	NULL
from	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
and	NULL
represents	NULL
a	NULL
C-to-T	NULL
exchange	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
this	NULL
exchange	NULL
creates	NULL
a	NULL
YY1	NULL
activation	NULL
site	NULL
.	NULL

mentary	NULL
DNA	NULL
(	NULL
cDNA	NULL
)	NULL
sequence	NULL
to	NULL
perform	NULL
three	NULL
cycles	NULL
of	NULL
inverse	NULL
PCR	NULL
(	NULL
GenBank	NULL
accession	NULL
#	NULL
:	NULL
UO6844	NULL
)	NULL
.	NULL

The	NULL
5	NULL
'	NULL
flanking	NULL
sequences	NULL
of	NULL
TGF-B1	NULL
,	NULL
-B2	NULL
,	NULL
and	NULL
-B3	NULL
were	NULL
obtained	NULL
from	NULL
Gen-Bank	NULL
.	NULL

We	NULL
identified	NULL
base	NULL
substitutions	NULL
as	NULL
the	NULL
detection	NULL
of	NULL
SSCP	NULL
s.	NULL
SSCP	NULL
demonstrated	NULL
one	NULL
polymorphism	NULL
within	NULL
the	NULL
first	NULL
1000	NULL
bp	NULL
of	NULL
the	NULL
IL-10	NULL
open	NULL
reading	NULL
frame	NULL
(	NULL
ORF	NULL
)	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

This	NULL
polymorphism	NULL
is	NULL
located	NULL
at	NULL
bp	NULL
~571	NULL
(	NULL
from	NULL
the	NULL
translation	NULL
start	NULL
site	NULL
)	NULL
and	NULL
represents	NULL
a	NULL
C-to-A	NULL
base	NULL
substitution	NULL
.	NULL

It	NULL
is	NULL
located	NULL
between	NULL
consensus	NULL
sequences	NULL
for	NULL
DNA	NULL
binding	NULL
by	NULL
two	NULL
types	NULL
of	NULL
transcription	NULL
factors	NULL
:	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
and	NULL
Spl	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

In	NULL
our	NULL
population	NULL
the	NULL
polymorphism	NULL
was	NULL
present	NULL
in	NULL
heterozygous	NULL
form	NULL
in	NULL
34	NULL
of	NULL
144	NULL
and	NULL
homozygous	NULL
form	NULL
in	NULL
13	NULL
of	NULL
144	NULL
subjects	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Four	NULL
polymorphisms	NULL
were	NULL
identified	NULL
in	NULL
the	NULL
TGF-B	NULL
promoters	NULL
.	NULL

These	NULL
include	NULL
a	NULL
base	NULL
exchange	NULL
at	NULL
bp	NULL
~509	NULL
as	NULL
well	NULL
as	NULL
two	NULL
between	NULL
~738	NULL
and	NULL
~1038	NULL
bp	NULL
from	NULL
the	NULL
first	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
of	NULL
TGF-B1	NULL
and	NULL
between	NULL
*13	NULL
and	NULL
~297	NULL
of	NULL
TGF-B2	NULL
.	NULL

No	NULL
polymorphisms	NULL
were	NULL
identified	NULL
in	NULL
TGF-B3	NULL
.	NULL

The	NULL
polymorphism	NULL
at	NULL
bp	NULL
509	NULL
represents	NULL
a	NULL
C-to-T	NULL
nucleotide	NULL
exchange	NULL
which	NULL
is	NULL
located	NULL
in	NULL
an	NULL
area	NULL
thought	NULL
to	NULL
be	NULL
a	NULL
negative	NULL
regulatory	NULL
region	NULL
(	NULL
11	NULL
)	NULL
and	NULL
creates	NULL
a	NULL
YY1	NULL
activator	NULL
consensus	NULL
sequence	NULL
(	NULL
12	NULL
)	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

The	NULL
polymorphism	NULL
is	NULL
present	NULL
in	NULL
heterozygous	NULL
form	NULL
in	NULL
77	NULL
of	NULL
144	NULL
TABLE	NULL
1	NULL
PREVALENCE	NULL
OF	NULL
THE	NULL
IL-10	NULL
AND	NULL
TGF-B	NULL
BASE	NULL
EXCHANGES	NULL
IN	NULL
FAMILIES	NULL
DEFINED	NULL
BY	NULL
THE	NULL
PRESENCE	NULL
OF	NULL
AN	NULL
ASTHM	NULL
ATIC	NULL
PROBAND	NULL
Homozygote	NULL
Homozygote	NULL
Gene	NULL
Wild	NULL
Type	NULL
Heterozygote	NULL
Base	NULL
Exchange	NULL
IL-10	NULL
(	NULL
C-to-A	NULL
at	NULL
~571*	NULL
)	NULL
97	NULL
34	NULL
13	NULL
TGFB1-1	NULL
(	NULL
C-to-T	NULL
at	NULL
~5091	NULL
)	NULL
51	NULL
77	NULL
16	NULL
TGF-B1-2	NULL
115	NULL
14	NULL
0	NULL
TGF-B1-3	NULL
(	NULL
~738-	NULL
1038	NULL
}	NULL
)	NULL
110	NULL
12	NULL
7	NULL
TGF-B2	NULL
(	NULL
297-4118	NULL
26	NULL
22	NULL
2	NULL
AMERICAN	NULL
.DURNAL	NULL
OF	NULL
RESPIRATORY	NULL
AND	NULL
CRITICAL	NULL
CAREMEDICINE	NULL
VOL	NULL
158	NULL
1998	NULL
subjects	NULL
and	NULL
in	NULL
homozygous	NULL
form	NULL
in	NULL
16	NULL
subjects	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
two	NULL
additional	NULL
polymorphisms	NULL
which	NULL
were	NULL
also	NULL
identified	NULL
in	NULL
the	NULL
TGF-B1	NULL
gene	NULL
were	NULL
not	NULL
further	NULL
characterized	NULL
or	NULL
sequenced	NULL
as	NULL
they	NULL
did	NULL
not	NULL
associate	NULL
with	NULL
any	NULL
of	NULL
the	NULL
phenotypic	NULL
markers	NULL
of	NULL
allergy	NULL
and	NULL
asthma	NULL
.	NULL

The	NULL
polymorphism	NULL
in	NULL
the	NULL
TGF-B2	NULL
promoter	NULL
is	NULL
located	NULL
in	NULL
a	NULL
region	NULL
which	NULL
may	NULL
be	NULL
important	NULL
in	NULL
influencing	NULL
promoter	NULL
strength	NULL
as	NULL
it	NULL
includes	NULL
the	NULL
TATAA	NULL
box	NULL
;	NULL
however	NULL
,	NULL
we	NULL
did	NULL
not	NULL
identify	NULL
any	NULL
associations	NULL
with	NULL
allergy	NULL
and	NULL
asthma	NULL
phenotypes	NULL
in	NULL
our	NULL
kindreds	NULL
.	NULL

No	NULL
additional	NULL
polymorphisms	NULL
were	NULL
identified	NULL
via	NULL
heteroduplex	NULL
analysis	NULL
.	NULL

Association	NULL
Studies	NULL
Support	NULL
for	NULL
a	NULL
phenotypic	NULL
influence	NULL
for	NULL
the	NULL
IL-10	NULL
base	NULL
exchange	NULL
at	NULL
bp	NULL
571	NULL
in	NULL
asthma	NULL
and	NULL
allergy	NULL
is	NULL
provided	NULL
by	NULL
data	NULL
derived	NULL
from	NULL
our	NULL
association	NULL
studies	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

For	NULL
IL-10	NULL
,	NULL
the	NULL
most	NULL
significant	NULL
linkage	NULL
was	NULL
observed	NULL
to	NULL
total	NULL
IgE	NULL
(	NULL
p	NULL
<	NULL
0.009	NULL
)	NULL
with	NULL
a	NULL
smaller	NULL
degree	NULL
of	NULL
significance	NULL
related	NULL
to	NULL
the	NULL
clinical	NULL
diagnosis	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
atopic	NULL
disease	NULL
(	NULL
allergic	NULL
rhinitis	NULL
,	NULL
asthma	NULL
,	NULL
or	NULL
atopic	NULL
dermatitis	NULL
;	NULL
p	NULL
=	NULL
0.05	NULL
)	NULL
.	NULL

The	NULL
mean	NULL
level	NULL
of	NULL
IgE	NULL
for	NULL
subjects	NULL
homozygous	NULL
for	NULL
the	NULL
polymorphism	NULL
is	NULL
350.0	NULL
*	NULL
145.1	NULL
as	NULL
compared	NULL
with	NULL
66.4	NULL
+	NULL
56.9	NULL
for	NULL
the	NULL
homozygous	NULL
wild	NULL
types	NULL
and	NULL
322.3	NULL
+	NULL
68.4	NULL
for	NULL
heterozygotes	NULL
.	NULL

These	NULL
IgE	NULL
data	NULL
suggest	NULL
a	NULL
dominant	NULL
influence	NULL
of	NULL
the	NULL
base	NULL
exchange	NULL
.	NULL

No	NULL
significant	NULL
linkages	NULL
were	NULL
observed	NULL
on	NULL
any	NULL
of	NULL
the	NULL
phenotypic	NULL
parameters	NULL
by	NULL
the	NULL
TGF-B1-1	NULL
base	NULL
exchange	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
total	NULL
IgE	NULL
(	NULL
p	NULL
<	NULL
0.01	NULL
)	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
IL-10	NULL
promoter	NULL
polymorphism	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
a	NULL
recessive	NULL
influence	NULL
.	NULL

Fi-nally	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
additive	NULL
influences	NULL
of	NULL
each	NULL
of	NULL
these	NULL
markers	NULL
on	NULL
total	NULL
IgE	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

A	NULL
synergistic	NULL
influence	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
TGF-B1-1	NULL
base	NULL
exchange	NULL
upon	NULL
the	NULL
IL-10	NULL
polymorphism	NULL
is	NULL
indicated	NULL
(	NULL
p	NULL
<	NULL
0.0001	NULL
)	NULL
.	NULL

We	NULL
could	NULL
not	NULL
independently	NULL
assess	NULL
the	NULL
influence	NULL
of	NULL
the	NULL
IL-10	NULL
exchange	NULL
on	NULL
TGF-B1	NULL
insofar	NULL
as	NULL
all	NULL
of	NULL
the	NULL
subjects	NULL
with	NULL
the	NULL
TGF-B1	NULL
exchange	NULL
were	NULL
also	NULL
polymorphic	NULL
at	NULL
the	NULL
IL-10	NULL
promoter	NULL
locus	NULL
.	NULL

DISCUSSION	NULL
The	NULL
absence	NULL
of	NULL
respiratory	NULL
inflammation	NULL
in	NULL
normal	NULL
,	NULL
non-atopic	NULL
,	NULL
nonasthmatic	NULL
subjects	NULL
is	NULL
maintained	NULL
by	NULL
influences	NULL
which	NULL
promote	NULL
the	NULL
development	NULL
of	NULL
nonresponsiveness	NULL
toward	NULL
otherwise	NULL
benign	NULL
inhaled	NULL
bioaerosols	NULL
.	NULL

The	NULL
cytokine	NULL
milieu	NULL
of	NULL
the	NULL
healthy	NULL
respiratory	NULL
tract	NULL
contributes	NULL
to	NULL
this	NULL
immune	NULL
nonresponsiveness	NULL
through	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
the	NULL
anti-inflammatory	NULL
cytokines	NULL
IL-10	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
and	NULL
TGF-B	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
IL-10	NULL
as	NULL
an	NULL
anti-inflammatory	NULL
cytokine	NULL
in	NULL
allergic	NULL
inflammation	NULL
has	NULL
recently	NULL
been	NULL
reviewed	NULL
(	NULL
13	NULL
)	NULL
.	NULL

IL-10	NULL
downregu-	NULL
TABLE	NULL
2	NULL
ASSOCIATION	NULL
OF	NULL
POLYM	NULL
ORPHISMS	NULL
WITH	NULL
SERUM	NULL
TOTAL	NULL
IgE	NULL
CONCENTRATIONS	NULL
IN	NULL
UNRELATED	NULL
ASTHMATIC	NULL
PROBANDS	NULL
IgE	NULL
Genotype	NULL
{	NULL
mean	NULL
+	NULL
SEM	NULL
)	NULL
p	NULL
Value*	NULL
IL-10	NULL
(	NULL
~571	NULL
)	NULL
<	NULL
0.009	NULL
Wild	NULL
type	NULL
C	NULL
,	NULL
C	NULL
66.4	NULL
+	NULL
56.9	NULL
Heterozygote	NULL
C	NULL
,	NULL
A	NULL
322.3	NULL
+	NULL
68.4	NULL
Base	NULL
exchange	NULL
AA	NULL
350.0	NULL
+	NULL
145.1	NULL
TGF-B1	NULL
(	NULL
~509	NULL
)	NULL
<	NULL
0.01	NULL
Wild	NULL
type	NULL
c	NULL
,	NULL
C	NULL
111.0	NULL
+	NULL
54.5	NULL
Heterozygote	NULL
C	NULL
,	NULL
.T	NULL
108.6	NULL
+	NULL
42.8	NULL
Base	NULL
exchange	NULL
T.T	NULL
703.0	NULL
+	NULL
100.9	NULL
Combination	NULL
<	NULL
0.0001	NULL
Wild	NULL
type	NULL
66.4	NULL
+	NULL
39.6	NULL
IL-10p	NULL
alone	NULL
200.7	NULL
+	NULL
53.9	NULL
TGFE-B1	NULL
alone	NULL
!	NULL

Both	NULL
exchanges	NULL
703.0	NULL
+	NULL
100.9	NULL
*	NULL
Location	NULL
of	NULL
base	NULL
exchange	NULL
in	NULL
relation	NULL
to	NULL
translation	NULL
start	NULL
site	NULL
.	NULL

*	NULL
Location	NULL
in	NULL
relation	NULL
to	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

*	NULL
ANOVA	NULL
.	NULL

*	NULL
All	NULL
of	NULL
the	NULL
patients	NULL
with	NULL
the	NULL
TGF-B1	NULL
polymorphism	NULL
were	NULL
also	NULL
polymorphic	NULL
for	NULL
IL-10	NULL
.	NULL

Hobbs	NULL
,	NULL
Negri	NULL
,	NULL
Klinnert	NULL
,	NULL
ef	NULL
a/	NULL
.	NULL

:	NULL
Gene	NULL
Polymorphisms	NULL
in	NULL
Allergies	NULL
and	NULL
Asthma	NULL
lates	NULL
IL-4	NULL
and	NULL
IL-5	NULL
expression	NULL
by	NULL
type	NULL
2	NULL
T-helper	NULL
cell	NULL
(	NULL
Th2	NULL
)	NULL
lymphocytes	NULL
(	NULL
14	NULL
)	NULL
.	NULL

IL-10	NULL
also	NULL
inhibits	NULL
accessory	NULL
cell	NULL
function	NULL
(	NULL
15	NULL
)	NULL
and	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-10	NULL
,	NULL
not	NULL
only	NULL
do	NULL
T	NULL
lymphocytes	NULL
not	NULL
proliferate	NULL
and	NULL
produce	NULL
cytokines	NULL
in	NULL
response	NULL
to	NULL
allergen	NULL
,	NULL
but	NULL
those	NULL
cells	NULL
are	NULL
rendered	NULL
irreversibly	NULL
nonresponsive	NULL
(	NULL
toler-ant	NULL
)	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Support	NULL
for	NULL
a	NULL
modulating	NULL
role	NULL
for	NULL
IL-10	NULL
in	NULL
human	NULL
allergic	NULL
diseases	NULL
is	NULL
further	NULL
derived	NULL
from	NULL
observations	NULL
that	NULL
IL-10	NULL
inhibits	NULL
eosinophil	NULL
survival	NULL
(	NULL
18	NULL
)	NULL
and	NULL
IgE	NULL
synthesis	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Administration	NULL
of	NULL
IL-10	NULL
to	NULL
sensitized	NULL
mice	NULL
abrogates	NULL
allergen-induced	NULL
airway	NULL
inflammation	NULL
(	NULL
20	NULL
)	NULL
.	NULL

IL-10	NULL
knockout	NULL
mice	NULL
develop	NULL
a	NULL
lethal	NULL
form	NULL
of	NULL
allergic	NULL
bronchopulmonary	NULL
aspergillosis	NULL
with	NULL
markedly	NULL
elevated	NULL
concentrations	NULL
of	NULL
interferon	NULL
gamma	NULL
(	NULL
IFN-y	NULL
)	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-5	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
healthy	NULL
lung	NULL
(	NULL
1	NULL
,	NULL
22	NULL
)	NULL
,	NULL
asthma	NULL
(	NULL
2	NULL
)	NULL
is	NULL
characterized	NULL
by	NULL
diminished	NULL
IL-10	NULL
production	NULL
,	NULL
which	NULL
will	NULL
contribute	NULL
to	NULL
the	NULL
development	NULL
of	NULL
an	NULL
inflammatory	NULL
milieu	NULL
.	NULL

The	NULL
inhibitory	NULL
effects	NULL
of	NULL
IL-10	NULL
are	NULL
in	NULL
contrast	NULL
to	NULL
its	NULL
effect	NULL
on	NULL
B	NULL
lymphocytes	NULL
where	NULL
it	NULL
stimulates	NULL
proliferation	NULL
and	NULL
immunoglobulin	NULL
secretion	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
IL-10	NULL
after	NULL
an	NULL
allergic	NULL
immune	NULL
response	NULL
has	NULL
been	NULL
allowed	NULL
to	NULL
develop	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
severity	NULL
of	NULL
these	NULL
responses	NULL
by	NULL
stimulating	NULL
IgE	NULL
secretion	NULL
from	NULL
B	NULL
lymphocytes	NULL
that	NULL
have	NULL
previously	NULL
undergone	NULL
the	NULL
&	NULL
isotype	NULL
switch	NULL
(	NULL
5	NULL
)	NULL
.	NULL

This	NULL
potential	NULL
role	NULL
for	NULL
IL-10	NULL
in	NULL
exacerbating	NULL
established	NULL
allergic	NULL
disorders	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
demonstration	NULL
of	NULL
enhanced	NULL
IL-10	NULL
secretion	NULL
in	NULL
atopic	NULL
dermatitis	NULL
(	NULL
25	NULL
)	NULL
and	NULL
our	NULL
observations	NULL
demonstrating	NULL
IL-10	NULL
transcription	NULL
after	NULL
an	NULL
allergen	NULL
challenge	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
IL-10	NULL
,	NULL
TGF-B	NULL
mediates	NULL
a	NULL
complex	NULL
mix	NULL
of	NULL
pro-and	NULL
anti-inflammatory	NULL
activities	NULL
.	NULL

TGF-B	NULL
represents	NULL
a	NULL
closely	NULL
related	NULL
family	NULL
of	NULL
peptides	NULL
of	NULL
which	NULL
TGF-B-1	NULL
,	NULL
-2	NULL
,	NULL
and	NULL
-3	NULL
are	NULL
expressed	NULL
in	NULL
humans	NULL
(	NULL
3	NULL
)	NULL
.	NULL

In	NULL
general	NULL
,	NULL
TGF-B	NULL
is	NULL
an	NULL
important	NULL
stimulant	NULL
of	NULL
fibrosis	NULL
,	NULL
inducing	NULL
formation	NULL
of	NULL
the	NULL
extracellular	NULL
matrix	NULL
and	NULL
fibrosis	NULL
.	NULL

In	NULL
immunity	NULL
,	NULL
however	NULL
,	NULL
its	NULL
predominant	NULL
functions	NULL
are	NULL
anti-inflammatory	NULL
.	NULL

TGF-B	NULL
,	NULL
like	NULL
IL-10	NULL
,	NULL
indirectly	NULL
inhibits	NULL
T-cell	NULL
activation	NULL
by	NULL
modulation	NULL
of	NULL
antigen-presenting	NULL
cell	NULL
function	NULL
and	NULL
deactivating	NULL
macrophages	NULL
(	NULL
3	NULL
,	NULL
26	NULL
)	NULL
.	NULL

TGF-B-like	NULL
IL-10-is	NULL
constitutively	NULL
expressed	NULL
in	NULL
the	NULL
lungs	NULL
(	NULL
4	NULL
,	NULL
27	NULL
)	NULL
.	NULL

TGF-B	NULL
knockout	NULL
mice	NULL
do	NULL
not	NULL
survive	NULL
secondary	NULL
to	NULL
diffuse	NULL
mononuclear	NULL
cell	NULL
infiltration	NULL
of	NULL
numerous	NULL
organs	NULL
including	NULL
the	NULL
lungs	NULL
(	NULL
28	NULL
)	NULL
.	NULL

TGF-B	NULL
may	NULL
help	NULL
prevent	NULL
the	NULL
development	NULL
of	NULL
allergic	NULL
inflammation	NULL
through	NULL
a	NULL
capacity	NULL
to	NULL
inhibit	NULL
IgE	NULL
synthesis	NULL
and	NULL
through	NULL
inhibition	NULL
of	NULL
mast	NULL
cell	NULL
proliferation	NULL
.	NULL

Addition-ally	NULL
,	NULL
TGF-B	NULL
abrogates	NULL
the	NULL
survival	NULL
effects	NULL
of	NULL
hematopoietins	NULL
on	NULL
eosinophils	NULL
and	NULL
thereby	NULL
induces	NULL
their	NULL
apoptosis	NULL
(	NULL
29	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
these	NULL
observations	NULL
supporting	NULL
an	NULL
anti-inflammatory	NULL
role	NULL
for	NULL
TGF-B	NULL
,	NULL
eosinophils	NULL
taken	NULL
from	NULL
the	NULL
nasal	NULL
tissue	NULL
of	NULL
subjects	NULL
with	NULL
allergic	NULL
rhinitis	NULL
as	NULL
well	NULL
as	NULL
from	NULL
nasal	NULL
polyposis	NULL
tissue	NULL
express	NULL
increased	NULL
amounts	NULL
of	NULL
TGF-B1	NULL
gene	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
secretion	NULL
of	NULL
TGF-B	NULL
after	NULL
an	NULL
allergic	NULL
disorder	NULL
has	NULL
developed	NULL
may	NULL
contribute	NULL
to	NULL
fibrosis	NULL
and	NULL
the	NULL
irreversible	NULL
changes	NULL
which	NULL
occur	NULL
with	NULL
long-standing	NULL
asthma	NULL
(	NULL
4	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
a	NULL
model	NULL
wherein	NULL
the	NULL
healthy	NULL
lung	NULL
maintains	NULL
an	NULL
appropriate	NULL
degree	NULL
of	NULL
nonresponsiveness	NULL
to	NULL
allergens	NULL
in	NULL
part	NULL
through	NULL
the	NULL
presence	NULL
of	NULL
TGF-B	NULL
and	NULL
IL-10	NULL
.	NULL

Influences	NULL
that	NULL
act	NULL
to	NULL
diminish	NULL
production	NULL
of	NULL
IL-10	NULL
or	NULL
TGF-B	NULL
will	NULL
enhance	NULL
any	NULL
underlying	NULL
proinflammatory	NULL
condition	NULL
.	NULL

Asthma	NULL
will	NULL
only	NULL
develop	NULL
in	NULL
the	NULL
additional	NULL
presence	NULL
of	NULL
influences	NULL
promoting	NULL
respiratory	NULL
inflammation	NULL
and	NULL
immune	NULL
responses	NULL
against	NULL
allergens	NULL
.	NULL

Both	NULL
IL-10	NULL
and	NULL
TGF-B	NULL
may	NULL
also	NULL
positively	NULL
contribute	NULL
to	NULL
the	NULL
severity	NULL
and	NULL
long-term	NULL
complications	NULL
of	NULL
established	NULL
inflammatory	NULL
disorders	NULL
including	NULL
asthma	NULL
.	NULL

Abnormal	NULL
regulatory	NULL
elements	NULL
within	NULL
the	NULL
IL-10	NULL
and	NULL
TGF-B	NULL
genes	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
development	NULL
of	NULL
allergies	NULL
and	NULL
asthma	NULL
(	NULL
or	NULL
other	NULL
inflammatory	NULL
disorders	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
studies	NULL
we	NULL
utilized	NULL
SSCP	NULL
to	NULL
demonstrate	NULL
the	NULL
existence	NULL
of	NULL
one	NULL
polymorphism	NULL
in	NULL
the	NULL
IL-10	NULL
promoter	NULL
,	NULL
three	NULL
in	NULL
the	NULL
TGF-B1	NULL
promoter	NULL
,	NULL
and	NULL
one	NULL
in	NULL
the	NULL
TGF-B2	NULL
promoter	NULL
.	NULL

Since	NULL
our	NULL
initial	NULL
1961	NULL
report	NULL
of	NULL
the	NULL
IL-10	NULL
promoter	NULL
polymorphism	NULL
(	NULL
31	NULL
)	NULL
,	NULL
this	NULL
same	NULL
base	NULL
exchange	NULL
has	NULL
been	NULL
reported	NULL
by	NULL
others	NULL
(	NULL
32	NULL
)	NULL
.	NULL

While	NULL
these	NULL
were	NULL
fairly	NULL
frequent	NULL
base	NULL
exchanges	NULL
in	NULL
our	NULL
cohort	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
our	NULL
subjects	NULL
were	NULL
recruited	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
asthmatic	NULL
proband	NULL
.	NULL

Thus	NULL
,	NULL
any	NULL
base	NULL
exchange	NULL
that	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
development	NULL
of	NULL
allergies	NULL
and	NULL
asthma	NULL
will	NULL
be	NULL
over-represented	NULL
,	NULL
and	NULL
as	NULL
such	NULL
,	NULL
these	NULL
data	NULL
do	NULL
not	NULL
accurately	NULL
report	NULL
the	NULL
frequency	NULL
of	NULL
our	NULL
polymorphisms	NULL
in	NULL
the	NULL
general	NULL
population	NULL
.	NULL

The	NULL
frequency	NULL
distributions	NULL
of	NULL
these	NULL
alleles	NULL
,	NULL
while	NULL
demonstrating	NULL
an	NULL
approximation	NULL
of	NULL
Hardy-Weinberg	NULL
distribution	NULL
,	NULL
were	NULL
not	NULL
in	NULL
equilibrium	NULL
for	NULL
IL-10	NULL
,	NULL
TGF-B1	NULL
and	NULL
-3	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
aberrations	NULL
induced	NULL
by	NULL
the	NULL
ascertainment	NULL
of	NULL
families	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
an	NULL
asthmatic	NULL
proband	NULL
,	NULL
this	NULL
may	NULL
also	NULL
have	NULL
occurred	NULL
secondary	NULL
to	NULL
the	NULL
inclusion	NULL
of	NULL
related	NULL
family	NULL
members	NULL
.	NULL

The	NULL
small	NULL
size	NULL
of	NULL
our	NULL
cohort	NULL
may	NULL
have	NULL
produced	NULL
sampling	NULL
error	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
data	NULL
presented	NULL
by	NULL
Turner	NULL
and	NULL
coworkers	NULL
(	NULL
32	NULL
)	NULL
demonstrate	NULL
Hardy-Weinberg	NULL
distribution	NULL
for	NULL
the	NULL
IL-10	NULL
promoter	NULL
base	NULL
exchange	NULL
.	NULL

As	NULL
such	NULL
,	NULL
it	NULL
is	NULL
more	NULL
likely	NULL
that	NULL
sampling	NULL
issues	NULL
explain	NULL
the	NULL
absence	NULL
of	NULL
expected	NULL
distribution	NULL
frequencies	NULL
,	NULL
rather	NULL
than	NULL
migration	NULL
of	NULL
these	NULL
mutations	NULL
into	NULL
the	NULL
population	NULL
.	NULL

The	NULL
strongest	NULL
phenotypic	NULL
association	NULL
of	NULL
our	NULL
polymorphisms	NULL
was	NULL
with	NULL
elevations	NULL
in	NULL
total	NULL
IgE	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
with	NULL
both	NULL
the	NULL
IL-10	NULL
and	NULL
TGF-B1	NULL
polymorphism	NULL
,	NULL
although	NULL
there	NULL
was	NULL
a	NULL
less	NULL
impressive	NULL
linkage	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
one	NULL
of	NULL
the	NULL
atopic	NULL
diseases	NULL
(	NULL
allergic	NULL
rhinitis	NULL
,	NULL
asthma	NULL
,	NULL
or	NULL
atopic	NULL
eczema	NULL
)	NULL
with	NULL
the	NULL
IL-10	NULL
base	NULL
exchange	NULL
.	NULL

Interestingly	NULL
,	NULL
synergistic	NULL
influences	NULL
were	NULL
observed	NULL
with	NULL
the	NULL
two	NULL
polymorphisms	NULL
on	NULL
IgE	NULL
production	NULL
.	NULL

Because	NULL
TGF-B1	NULL
and	NULL
IL-10	NULL
genes	NULL
are	NULL
on	NULL
different	NULL
chromosomes	NULL
(	NULL
19q	NULL
and	NULL
1q	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
these	NULL
genes	NULL
clearly	NULL
will	NULL
segregate	NULL
independently	NULL
.	NULL

TGF-B	NULL
may	NULL
inhibit	NULL
the	NULL
isotype	NULL
switch	NULL
to	NULL
IgE	NULL
(	NULL
33	NULL
)	NULL
and	NULL
as	NULL
such	NULL
base	NULL
exchanges	NULL
that	NULL
increase	NULL
TGF-B	NULL
expression	NULL
may	NULL
be	NULL
predicted	NULL
to	NULL
affect	NULL
total	NULL
IgE	NULL
concentrations	NULL
.	NULL

As	NULL
discussed	NULL
,	NULL
IL-10	NULL
may	NULL
positively	NULL
or	NULL
negatively	NULL
influence	NULL
IgE	NULL
by	NULL
either	NULL
inhibiting	NULL
the	NULL
&	NULL
isotype	NULL
switch	NULL
through	NULL
inhibition	NULL
of	NULL
IL-4	NULL
and	NULL
IL-13	NULL
(	NULL
13	NULL
,	NULL
19	NULL
)	NULL
or	NULL
by	NULL
stimulating	NULL
IgE	NULL
release	NULL
from	NULL
committed	NULL
B	NULL
lymphocytes	NULL
(	NULL
5	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Our	NULL
demonstrated	NULL
association	NULL
between	NULL
total	NULL
IgE	NULL
and	NULL
the	NULL
IL-10	NULL
polymorphism	NULL
therefore	NULL
can	NULL
not	NULL
predict	NULL
whether	NULL
this	NULL
polymorphism	NULL
acts	NULL
to	NULL
promote	NULL
or	NULL
inhibit	NULL
IL-10	NULL
production	NULL
.	NULL

No	NULL
associations	NULL
were	NULL
identified	NULL
between	NULL
the	NULL
two	NULL
further	NULL
upstream	NULL
polymorphisms	NULL
in	NULL
the	NULL
TGF-B1	NULL
promoter	NULL
nor	NULL
the	NULL
base	NULL
exchange	NULL
in	NULL
the	NULL
TGF-B2	NULL
promoter	NULL
with	NULL
any	NULL
of	NULL
our	NULL
phenotypic	NULL
markers	NULL
of	NULL
allergy	NULL
and	NULL
asthma	NULL
.	NULL

This	NULL
does	NULL
not	NULL
preclude	NULL
the	NULL
possible	NULL
importance	NULL
in	NULL
other	NULL
kindreds	NULL
or	NULL
in	NULL
other	NULL
immune	NULL
and	NULL
inflammatory	NULL
disorders	NULL
.	NULL

Unfortunately	NULL
,	NULL
our	NULL
sample	NULL
size	NULL
was	NULL
too	NULL
small	NULL
and	NULL
therefore	NULL
may	NULL
have	NULL
lacked	NULL
the	NULL
power	NULL
to	NULL
detect	NULL
additional	NULL
significant	NULL
associations	NULL
.	NULL

It	NULL
is	NULL
to	NULL
be	NULL
hoped	NULL
that	NULL
other	NULL
groups	NULL
with	NULL
larger	NULL
cohorts	NULL
of	NULL
phenotyped	NULL
individuals	NULL
can	NULL
confirm	NULL
the	NULL
importance	NULL
of	NULL
these	NULL
linkages	NULL
and	NULL
extend	NULL
them	NULL
to	NULL
other	NULL
phenotypic	NULL
markers	NULL
of	NULL
allergies	NULL
and	NULL
asthma	NULL
.	NULL

Confirmation	NULL
of	NULL
the	NULL
IgE	NULL
associations	NULL
in	NULL
unrelated	NULL
cohorts	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
is	NULL
essential	NULL
in	NULL
studying	NULL
the	NULL
genetics	NULL
of	NULL
complex	NULL
disorders	NULL
.	NULL

The	NULL
base	NULL
substitutions	NULL
we	NULL
have	NULL
identified	NULL
may	NULL
not	NULL
have	NULL
functional	NULL
significance	NULL
for	NULL
the	NULL
development	NULL
of	NULL
allergies	NULL
or	NULL
asthma	NULL
.	NULL

Our	NULL
data	NULL
supporting	NULL
an	NULL
association	NULL
of	NULL
the	NULL
polymorphisms	NULL
with	NULL
IgE	NULL
dysregulation	NULL
,	NULL
along	NULL
with	NULL
the	NULL
observations	NULL
derived	NULL
from	NULL
the	NULL
IL-10	NULL
and	NULL
TGF-B	NULL
knockout	NULL
mice	NULL
,	NULL
support	NULL
the	NULL
ability	NULL
of	NULL
dysregulated	NULL
transcription	NULL
of	NULL
these	NULL
cytokines	NULL
to	NULL
play	NULL
a	NULL
causative	NULL
role	NULL
in	NULL
the	NULL
development	NULL
of	NULL
allergic	NULL
inflamma-tion	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
recent	NULL
report	NULL
of	NULL
a	NULL
linkage	NULL
of	NULL
the	NULL
base	NULL
exchange	NULL
in	NULL
the	NULL
IL-10	NULL
promoter	NULL
with	NULL
severity	NULL
of	NULL
systemic	NULL
lupus	NULL
erythematosus	NULL
supports	NULL
the	NULL
concept	NULL
that	NULL
this	NULL
polymorphism	NULL
contributes	NULL
to	NULL
the	NULL
presence	NULL
or	NULL
severity	NULL
of	NULL
immune	NULL
disorders	NULL
(	NULL
34	NULL
)	NULL
.	NULL

There	NULL
are	NULL
,	NULL
however	NULL
,	NULL
several	NULL
alternative	NULL
explanations	NULL
.	NULL

Linkage	NULL
disequilibrium	NULL
may	NULL
be	NULL
present	NULL
with	NULL
the	NULL
actual	NULL
responsible	NULL
polymorphism	NULL
.	NULL

More	NULL
problematic	NULL
are	NULL
difficulties	NULL
with	NULL
our	NULL
use	NULL
of	NULL
association	NULL
studies	NULL
.	NULL

One	NULL
argument	NULL
for	NULL
per	NULL
1962	NULL
forming	NULL
association	NULL
analysis	NULL
is	NULL
that	NULL
our	NULL
specific	NULL
aim	NULL
was	NULL
to	NULL
identify	NULL
asthma	NULL
and	NULL
allergy	NULL
``	NULL
genes	NULL
``	NULL
and	NULL
not	NULL
genetic	NULL
markers	NULL
that	NULL
link	NULL
to	NULL
these	NULL
conditions	NULL
.	NULL

The	NULL
difficulty	NULL
with	NULL
association	NULL
studies	NULL
is	NULL
that	NULL
they	NULL
can	NULL
not	NULL
distinguish	NULL
true	NULL
linkages	NULL
from	NULL
identical	NULL
patterns	NULL
which	NULL
can	NULL
occur	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
population	NULL
stratification	NULL
in	NULL
the	NULL
distribution	NULL
of	NULL
a	NULL
given	NULL
allele	NULL
.	NULL

Such	NULL
population	NULL
heterogeneity	NULL
has	NULL
plagued	NULL
the	NULL
asthma	NULL
genetics	NULL
literature	NULL
and	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
myriad	NULL
of	NULL
studies	NULL
that	NULL
have	NULL
identified	NULL
significant	NULL
linkages	NULL
in	NULL
one	NULL
population	NULL
which	NULL
are	NULL
not	NULL
reproducible	NULL
by	NULL
other	NULL
investigators	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
surprisingly	NULL
large	NULL
influence	NULL
on	NULL
phenotype	NULL
,	NULL
association	NULL
studies	NULL
are	NULL
the	NULL
primary	NULL
mechanism	NULL
for	NULL
screening	NULL
for	NULL
disease	NULL
linkages	NULL
in	NULL
complex	NULL
disorders	NULL
such	NULL
as	NULL
asthma	NULL
.	NULL

While	NULL
population	NULL
stratification	NULL
may	NULL
have	NULL
produced	NULL
false-positive	NULL
results	NULL
in	NULL
the	NULL
current	NULL
study	NULL
,	NULL
this	NULL
will	NULL
be	NULL
addressed	NULL
in	NULL
part	NULL
by	NULL
other	NULL
asthma	NULL
geneticists	NULL
evaluating	NULL
the	NULL
role	NULL
of	NULL
our	NULL
polymorphisms	NULL
in	NULL
their	NULL
own	NULL
unrelated	NULL
populations	NULL
.	NULL

Most	NULL
importantly	NULL
,	NULL
the	NULL
genetic	NULL
role	NULL
for	NULL
these	NULL
polymorphisms	NULL
in	NULL
asthma	NULL
,	NULL
allergy	NULL
,	NULL
and	NULL
other	NULL
immune	NULL
diseases	NULL
will	NULL
be	NULL
established	NULL
by	NULL
performing	NULL
functional	NULL
molecular	NULL
biological	NULL
studies	NULL
.	NULL

Polymorphisms	NULL
that	NULL
influence	NULL
transcription	NULL
factor	NULL
interaction	NULL
with	NULL
the	NULL
gene	NULL
promoters	NULL
,	NULL
modify	NULL
promoter	NULL
strength	NULL
,	NULL
and	NULL
thereby	NULL
modulate	NULL
gene	NULL
expression	NULL
will	NULL
be	NULL
established	NULL
as	NULL
having	NULL
phenotypic	NULL
influences	NULL
.	NULL

For	NULL
example	NULL
,	NULL
our	NULL
current	NULL
studies	NULL
have	NULL
demonstrated	NULL
an	NULL
increased	NULL
binding	NULL
affinity	NULL
of	NULL
Spl	NULL
and	NULL
one	NULL
other	NULL
uncharacterized	NULL
transcription	NULL
factor	NULL
to	NULL
IL-10	NULL
promoters	NULL
containing	NULL
C	NULL
at	NULL
bp	NULL
571	NULL
,	NULL
and	NULL
have	NULL
shown	NULL
that	NULL
this	NULL
is	NULL
associated	NULL
with	NULL
increased	NULL
promoter	NULL
strength	NULL
(	NULL
Borish	NULL
and	NULL
colleagues	NULL
,	NULL
submitted	NULL
manuscript	NULL
)	NULL
.	NULL

Individuals	NULL
with	NULL
this	NULL
form	NULL
of	NULL
the	NULL
IL-10	NULL
promoter	NULL
may	NULL
therefore	NULL
demonstrate	NULL
enhanced	NULL
synthesis	NULL
of	NULL
IL-10	NULL
,	NULL
thereby	NULL
influencing	NULL
the	NULL
intensity	NULL
of	NULL
their	NULL
immune	NULL
responses	NULL
and	NULL
producing	NULL
the	NULL
associations	NULL
observed	NULL
in	NULL
these	NULL
studies	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Bonfield	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
M.	NULL
W.	NULL
Konstan	NULL
,	NULL
P.	NULL
Burfeind	NULL
,	NULL
J.	NULL
R.	NULL
Panuska	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Hilliard	NULL
,	NULL
and	NULL
M.	NULL
Berger	NULL
.	NULL

1995	NULL
.	NULL

Normal	NULL
bronchial	NULL
epithelial	NULL
cells	NULL
constitutively	NULL
produce	NULL
the	NULL
anti-inflammatory	NULL
cytokine	NULL
interleukin-10	NULL
,	NULL
which	NULL
is	NULL
down-regulated	NULL
in	NULL
cystic	NULL
fibrosis	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

13:257-261	NULL
.	NULL

2	NULL
.	NULL

Borish	NULL
,	NULL
L.	NULL
,	NULL
A.	NULL
Aarons	NULL
,	NULL
J.	NULL
Rumbyrt	NULL
,	NULL
P.	NULL
Cvietusa	NULL
,	NULL
J.	NULL
Negri	NULL
,	NULL
and	NULL
S.	NULL
Wenzel	NULL
.	NULL

1996	NULL
.	NULL

Interleukin-10	NULL
regulation	NULL
in	NULL
normal	NULL
and	NULL
asthmatic	NULL
subjects	NULL
.	NULL

J	NULL
.	NULL

Allergy	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

97:1288-1296	NULL
.	NULL

3	NULL
.	NULL

McCartney-Francis	NULL
,	NULL
N.	NULL
L.	NULL
,	NULL
and	NULL
S.	NULL
Wahl	NULL
.	NULL

1995	NULL
.	NULL

Transforming	NULL
growth	NULL
factor	NULL
beta	NULL
:	NULL
a	NULL
matter	NULL
of	NULL
life	NULL
and	NULL
death	NULL
.	NULL

J.	NULL
L	NULL
ewk	NULL
.	NULL

Biol	NULL
.	NULL

55:401-409	NULL
.	NULL

4	NULL
.	NULL

Aubert	NULL
,	NULL
J.-D.	NULL
,	NULL
B.	NULL
I.	NULL
Dalal	NULL
,	NULL
T.	NULL
R.	NULL
Bai	NULL
,	NULL
C.	NULL
R.	NULL
Roberts	NULL
,	NULL
S.	NULL
Hayashi	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Hogg	NULL
.	NULL

1994	NULL
.	NULL

Transforming	NULL
growth	NULL
factor	NULL
B1	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
airways	NULL
.	NULL

Thorax	NULL
49:225-232	NULL
.	NULL

5	NULL
.	NULL

Ohmori	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Kanda	NULL
,	NULL
T.	NULL
Takai	NULL
,	NULL
and	NULL
M.	NULL
Hikida	NULL
.	NULL

1995	NULL
.	NULL

Induction	NULL
of	NULL
antigen-specific	NULL
IgE	NULL
response	NULL
in	NULL
murine	NULL
lymphocytes	NULL
by	NULL
IL-10	NULL
.	NULL

Immunol	NULL
.	NULL

L	NULL
eft	NULL
.	NULL

47:127-132	NULL
.	NULL

6	NULL
.	NULL

Mrazek	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
M.	NULL
Klinnert	NULL
,	NULL
P.	NULL
Mrazek	NULL
,	NULL
and	NULL
T.	NULL
Macey	NULL
.	NULL

1991	NULL
.	NULL

Early	NULL
asthma	NULL
onset	NULL
:	NULL
consideration	NULL
of	NULL
parenting	NULL
issues	NULL
.	NULL

J	NULL
.	NULL

Am	NULL
.	NULL

Acad	NULL
.	NULL

Child	NULL
.	NULL

Adolescent	NULL
Psych	NULL
.	NULL

30:277-282	NULL
.	NULL

7	NULL
.	NULL

Klinnert	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Mrazek	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Mrazek	NULL
.	NULL

1994	NULL
.	NULL

Early	NULL
asthma	NULL
onset	NULL
:	NULL
the	NULL
interaction	NULL
between	NULL
family	NULL
stressors	NULL
and	NULL
adaptive	NULL
parenting	NULL
.	NULL

Psychiatry	NULL
57:51-61	NULL
.	NULL

8	NULL
.	NULL

Orita	NULL
,	NULL
M.	NULL
,	NULL
Y.	NULL
Suzuki	NULL
,	NULL
T.	NULL
Sekiya	NULL
,	NULL
and	NULL
K.	NULL
Hayashi	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
and	NULL
sensitive	NULL
detection	NULL
of	NULL
point	NULL
mutations	NULL
and	NULL
DNA	NULL
polymorphisms	NULL
using	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Genomics	NULL
5:874-879	NULL
.	NULL

9	NULL
.	NULL

Orita	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Iwahana	NULL
,	NULL
H.	NULL
Kanazawa	NULL
,	NULL
K.	NULL
Hayashi	NULL
,	NULL
and	NULL
T.	NULL
Sekiya	NULL
.	NULL

1989	NULL
.	NULL

Detection	NULL
of	NULL
polymorphisms	NULL
of	NULL
human	NULL
DNA	NULL
by	NULL
gel	NULL
electrophoresis	NULL
as	NULL
a	NULL
single-stranded	NULL
conformation	NULL
polymorphism	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.8	NULL
.	NULL

A	NULL
.	NULL

86:2766-2770	NULL
.	NULL

10	NULL
.	NULL

Van	NULL
den	NULL
Akker	NULL
,	NULL
E.	NULL
,	NULL
J.	NULL
E.	NULL
F.	NULL
Braun	NULL
,	NULL
G.	NULL
Pals	NULL
,	NULL
M.	NULL
V.	NULL
M.	NULL
Lafleur	NULL
,	NULL
and	NULL
J.	NULL
Re-tel	NULL
.	NULL

1992	NULL
.	NULL

Single	NULL
base	NULL
mutations	NULL
can	NULL
be	NULL
unequivocally	NULL
and	NULL
rapidly	NULL
detected	NULL
by	NULL
analysis	NULL
of	NULL
DNA	NULL
heteroduplexes	NULL
,	NULL
obtained	NULL
with	NULL
deletion-mutant	NULL
instead	NULL
of	NULL
wild	NULL
type	NULL
DNA	NULL
.	NULL

Nucleic	NULL
A	NULL
cids	NULL
Res	NULL
.	NULL

20:6745-6746	NULL
.	NULL

11	NULL
.	NULL

Kim	NULL
,	NULL
S.-J	NULL
.	NULL

,	NULL
A.	NULL
Glick	NULL
,	NULL
M.	NULL
B.	NULL
Sporn	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Roberts	NULL
.	NULL

1989	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
human	NULL
transforming	NULL
growth	NULL
factor-B1	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:402-408	NULL
.	NULL

12	NULL
.	NULL

Shrivastava	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
analysis	NULL
of	NULL
genes	NULL
regulated	NULL
by	NULL
the	NULL
multi-functional	NULL
transcriptional	NULL
regulatory	NULL
Yin	NULL
Yang-1	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

24:5151-5155	NULL
.	NULL

AMERICAN	NULL
.DURNAL	NULL
OF	NULL
RESPIRATORY	NULL
AND	NULL
CRITICAL	NULL
CAREMEDICINE	NULL
VOL158	NULL
1998	NULL
13	NULL
.	NULL

Borish	NULL
,	NULL
L.	NULL
Interleukin-10	NULL
:	NULL
evolving	NULL
concepts	NULL
.	NULL

J	NULL
.	NULL

A	NULL
fergy	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

(	NULL
In	NULL
press	NULL
)	NULL
14	NULL
.	NULL

Del	NULL
Prete	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
De	NULL
Carli	NULL
,	NULL
F.	NULL
Almerigogna	NULL
,	NULL
M.	NULL
G.	NULL
Giudizi	NULL
,	NULL
R.	NULL
Biagiotti	NULL
,	NULL
and	NULL
S.	NULL
Romagnani	NULL
.	NULL

1993	NULL
.	NULL

Human	NULL
IL-10	NULL
is	NULL
produced	NULL
by	NULL
both	NULL
type	NULL
1	NULL
helper	NULL
(	NULL
Th1	NULL
)	NULL
and	NULL
type	NULL
2	NULL
helper	NULL
(	NULL
Th2	NULL
)	NULL
T	NULL
cell	NULL
clones	NULL
and	NULL
inhibits	NULL
their	NULL
antigen-specific	NULL
proliferation	NULL
and	NULL
cytokine	NULL
production	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:353-360	NULL
.	NULL

15.	NULL
de	NULL
Waal	NULL
Malefyt	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Haanen	NULL
,	NULL
H.	NULL
Spits	NULL
,	NULL
M.	NULL
G.	NULL
Roncarolo	NULL
,	NULL
A.	NULL
te	NULL
Velde	NULL
,	NULL
C.	NULL
Figdor	NULL
,	NULL
K.	NULL
Johnson	NULL
,	NULL
R.	NULL
Kastelein	NULL
,	NULL
H.	NULL
Yssel	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
de	NULL
Vries	NULL
.	NULL

1991	NULL
.	NULL

Interleukin	NULL
10	NULL
(	NULL
IL-10	NULL
)	NULL
and	NULL
viral	NULL
IL-10	NULL
strongly	NULL
reduce	NULL
antigen-specific	NULL
human	NULL
T	NULL
cell	NULL
proliferation	NULL
by	NULL
diminishing	NULL
the	NULL
antigen-presenting	NULL
capacity	NULL
of	NULL
monocytes	NULL
via	NULL
downregulation	NULL
of	NULL
class	NULL
II	NULL
major	NULL
histocompat-ibility	NULL
complex	NULL
expression	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174:915-924	NULL
.	NULL

16	NULL
.	NULL

Enk	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
V.	NULL
L.	NULL
Angeloni	NULL
,	NULL
M.	NULL
C.	NULL
Udey	NULL
,	NULL
and	NULL
S.	NULL
I.	NULL
Katz	NULL
.	NULL

1993	NULL
.	NULL

Inhibition	NULL
of	NULL
Langerhans	NULL
cell	NULL
antigen-presenting	NULL
function	NULL
by	NULL
IL-10	NULL
:	NULL
a	NULL
role	NULL
for	NULL
IL-10	NULL
in	NULL
induction	NULL
of	NULL
tolerance	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:2390-2398	NULL
.	NULL

17	NULL
.	NULL

Becker	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
C.	NULL
Czerny	NULL
,	NULL
and	NULL
E.-B	NULL
.	NULL

Brocker	NULL
.	NULL

1994	NULL
.	NULL

Maintenance	NULL
of	NULL
clonal	NULL
anergy	NULL
by	NULL
endogenously	NULL
produced	NULL
IL-10	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

6:1605-1612	NULL
.	NULL

18	NULL
.	NULL

Takanaski	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Nonaka	NULL
,	NULL
Z.	NULL
Xing	NULL
,	NULL
P.	NULL
O'Byrne	NULL
,	NULL
J.	NULL
Dolovich	NULL
,	NULL
and	NULL
M.	NULL
Jordana	NULL
.	NULL

1994	NULL
.	NULL

Interleukin	NULL
10	NULL
inhibits	NULL
lipopolysaccharide-induced	NULL
survival	NULL
and	NULL
cytokine	NULL
production	NULL
by	NULL
human	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:711-715	NULL
.	NULL

19	NULL
.	NULL

Punnonen	NULL
,	NULL
J.	NULL
,	NULL
R.	NULL
de	NULL
Waal	NULL
Malefyt	NULL
,	NULL
P.	NULL
Van	NULL
Vlasselae	NULL
,	NULL
J.-F.	NULL
Gauchat	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
de	NULL
Vries	NULL
.	NULL

1993	NULL
.	NULL

IL-10	NULL
and	NULL
viral	NULL
IL-10	NULL
prevent	NULL
IL-4-induced	NULL
IgE	NULL
synthesis	NULL
by	NULL
inhibiting	NULL
the	NULL
accessory	NULL
cell	NULL
function	NULL
of	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:1280-1289	NULL
.	NULL

20	NULL
.	NULL

Zuany-Amorim	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
Haile	NULL
,	NULL
D.	NULL
Leduc	NULL
,	NULL
C.	NULL
Dumarey	NULL
,	NULL
M.	NULL
Huerre	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
Vargaftig	NULL
,	NULL
and	NULL
M.	NULL
Pretolani	NULL
.	NULL

1995	NULL
.	NULL

Interleukin-10	NULL
inhibits	NULL
antigen-induced	NULL
cellular	NULL
recruitment	NULL
into	NULL
the	NULL
airways	NULL
of	NULL
sensitized	NULL
mice	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

95:2644-2651	NULL
.	NULL

21	NULL
.	NULL

Grunig	NULL
,	NULL
G.	NULL
,	NULL
D.	NULL
B.	NULL
Corry	NULL
,	NULL
M.	NULL
W.	NULL
Leach	NULL
,	NULL
B.	NULL
W.	NULL
P.	NULL
Seymour	NULL
,	NULL
V.	NULL
P.	NULL
Kurup	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Rennick	NULL
.	NULL

1997	NULL
.	NULL

Interleukin-10	NULL
is	NULL
a	NULL
natural	NULL
suppressor	NULL
of	NULL
cytokine	NULL
production	NULL
and	NULL
inflammation	NULL
in	NULL
a	NULL
murine	NULL
model	NULL
of	NULL
allergic	NULL
bronchopulmonary	NULL
aspergillosis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:1089-1099	NULL
.	NULL

22	NULL
.	NULL

Martinez	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

B.	NULL
,	NULL
T.	NULL
E.	NULL
King	NULL
,	NULL
Jr.	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
C.	NULL
A.	NULL
Jennings	NULL
,	NULL
L.	NULL
Borish	NULL
,	NULL
R.	NULL
L.	NULL
Mortenson	NULL
,	NULL
T.	NULL
Z.	NULL
Khan	NULL
,	NULL
T.	NULL
W.	NULL
Bost	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
H.	NULL
Riches	NULL
.	NULL

1997	NULL
.	NULL

Increased	NULL
expression	NULL
of	NULL
the	NULL
interleukin	NULL
10	NULL
gene	NULL
in	NULL
alveolar	NULL
macrophages	NULL
in	NULL
interstitial	NULL
lung	NULL
diseases	NULL
.	NULL

L	NULL
ung	NULL
Cell	NULL
.	NULL

Mol	NULL
.	NULL

Physiol	NULL
.	NULL

17:1L676-683	NULL
.	NULL

23	NULL
.	NULL

Rousset	NULL
,	NULL
F.	NULL
,	NULL
E.	NULL
Garcia	NULL
,	NULL
T.	NULL
Defrance	NULL
,	NULL
C.	NULL
Peronne	NULL
,	NULL
N.	NULL
Vezzio	NULL
,	NULL
D.	NULL
H.	NULL
Hsu	NULL
,	NULL
R.	NULL
Kastelein	NULL
,	NULL
K.	NULL
W.	NULL
Moore	NULL
,	NULL
and	NULL
J.	NULL
Banchereau	NULL
.	NULL

1992	NULL
.	NULL

Interleukin	NULL
10	NULL
is	NULL
a	NULL
potent	NULL
growth	NULL
and	NULL
differentiation	NULL
factor	NULL
for	NULL
activated	NULL
human	NULL
B	NULL
lym-phocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

A	NULL
cad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
89:1890-1893	NULL
.	NULL

24	NULL
.	NULL

Briere	NULL
,	NULL
F.	NULL
,	NULL
C.	NULL
Servet-Delprat	NULL
,	NULL
J.-M.	NULL
Bridon	NULL
,	NULL
J.-M.	NULL
Saint-Remy	NULL
,	NULL
and	NULL
J.	NULL
Banchereau	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
interleukin	NULL
10	NULL
induces	NULL
naive	NULL
surface	NULL
immunoglobulin	NULL
D+	NULL
(	NULL
sIgD+	NULL
)	NULL
B	NULL
cells	NULL
to	NULL
secrete	NULL
IgG	NULL
1	NULL
and	NULL
IgG3	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179:757-1762	NULL
.	NULL

25	NULL
.	NULL

Ohmen	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
J.	NULL
M.	NULL
Hanifin	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Nickoloff	NULL
.	NULL

1995	NULL
.	NULL

Overexpression	NULL
of	NULL
IL-10	NULL
in	NULL
atopic	NULL
dermatitis	NULL
:	NULL
contrasting	NULL
cytokine	NULL
patterns	NULL
with	NULL
de-layed-type	NULL
hypersensitivity	NULL
reactions	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:1956-1963	NULL
.	NULL

26	NULL
.	NULL

Tsunawaki	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Sporn	NULL
,	NULL
A.	NULL
Ding	NULL
,	NULL
and	NULL
C.	NULL
Nathan	NULL
.	NULL

1988	NULL
.	NULL

Deactivation	NULL
of	NULL
macrophages	NULL
by	NULL
transforming	NULL
growth	NULL
factor-B	NULL
.	NULL

Nature	NULL
334:260-262	NULL
.	NULL

27	NULL
.	NULL

Toossi	NULL
,	NULL
Z	NULL
.	NULL

1996	NULL
.	NULL

Decreased	NULL
production	NULL
of	NULL
TGFB-1	NULL
by	NULL
human	NULL
alveolar	NULL
macrophages	NULL
as	NULL
compared	NULL
with	NULL
blood	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156	NULL
:	NULL
3461-3468	NULL
.	NULL

28	NULL
.	NULL

Shull	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
I.	NULL
Ormsby	NULL
,	NULL
A.	NULL
Kier	NULL
,	NULL
S.	NULL
Pawlowski	NULL
,	NULL
R.	NULL
J.	NULL
Diebold	NULL
,	NULL
M.	NULL
Yin	NULL
,	NULL
R.	NULL
Allen	NULL
,	NULL
C.	NULL
Sidman	NULL
,	NULL
G.	NULL
Proctzel	NULL
,	NULL
and	NULL
D.	NULL
Calvin	NULL
.	NULL

1992	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
mouse	NULL
transforming	NULL
growth	NULL
factor-B1	NULL
gene	NULL
results	NULL
in	NULL
multi-focal	NULL
inflammatory	NULL
disease	NULL
.	NULL

Nature	NULL
359:693-699	NULL
.	NULL

29	NULL
.	NULL

Alam	NULL
,	NULL
R.	NULL
1994	NULL
.	NULL

Transforming	NULL
growth	NULL
factor	NULL
B	NULL
abrogates	NULL
the	NULL
effects	NULL
of	NULL
hematopoictins	NULL
on	NULL
eosinophils	NULL
and	NULL
induces	NULL
their	NULL
apoptosis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179:1041-1045	NULL
.	NULL

30	NULL
.	NULL

Ohno	NULL
,	NULL
I.	NULL
,	NULL
R.	NULL
G.	NULL
Lea	NULL
,	NULL
K.	NULL
C.	NULL
Flanders	NULL
,	NULL
D.	NULL
A.	NULL
Clark	NULL
,	NULL
D.	NULL
Banwatt	NULL
,	NULL
J.	NULL
Dolovich	NULL
,	NULL
J.	NULL
Denburg	NULL
,	NULL
C.	NULL
B.	NULL
Harley	NULL
,	NULL
J.	NULL
Gauldie	NULL
,	NULL
and	NULL
M.	NULL
Jordana	NULL
.	NULL

1992	NULL
.	NULL

Eosinophils	NULL
in	NULL
chronically	NULL
inflamed	NULL
human	NULL
upper	NULL
airway	NULL
tissues	NULL
express	NULL
transforming	NULL
growth	NULL
factor	NULL
B1	NULL
gene	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

89:1662-1668	NULL
.	NULL

31	NULL
.	NULL

Mascali	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Borish	NULL
,	NULL
A.	NULL
Aarons	NULL
.	NULL

J.	NULL
Rumbyrt	NULL
,	NULL
and	NULL
D.	NULL
Klemm	NULL
.	NULL

1995	NULL
.	NULL

Sequence	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-10	NULL
promoter	NULL
(	NULL
abstract	NULL
)	NULL
.	NULL

J	NULL
.	NULL

A	NULL
Hergy	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

95:343A	NULL
.	NULL

32	NULL
.	NULL

Turner	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
D.	NULL
M.	NULL
Williams	NULL
,	NULL
D.	NULL
Sankaran	NULL
,	NULL
M.	NULL
Lazarus	NULL
,	NULL
P.	NULL
J.	NULL
Sinnott	NULL
,	NULL
and	NULL
I.	NULL
V.	NULL
Hutchinson	NULL
.	NULL

1997	NULL
.	NULL

An	NULL
investigation	NULL
of	NULL
polymorphisms	NULL
in	NULL
the	NULL
interleukin-10	NULL
gene	NULL
promoter	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunogenet	NULL
.	NULL

24:1-8	NULL
.	NULL

33	NULL
.	NULL

Kebrl	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
C.	NULL
Thevenin	NULL
,	NULL
P.	NULL
Rieckmann	NULL
,	NULL
and	NULL
A.	NULL
Fauci	NULL
.	NULL

1991	NULL
.	NULL

Transforming	NULL
growth	NULL
factor-B	NULL
suppresses	NULL
human	NULL
B	NULL
lymphocyte	NULL
Ig	NULL
production	NULL
by	NULL
inhibiting	NULL
synthesis	NULL
and	NULL
the	NULL
switch	NULL
from	NULL
the	NULL
membrane	NULL
form	NULL
to	NULL
the	NULL
secreted	NULL
form	NULL
of	NULL
Ig	NULL
mRNA	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:4016-4023	NULL
.	NULL

34	NULL
.	NULL

Lazarus	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
H.	NULL
Hajeer	NULL
,	NULL
D.	NULL
Turner	NULL
,	NULL
P.	NULL
Sinnott	NULL
,	NULL
J.	NULL
Worthington	NULL
,	NULL
W.	NULL
E.	NULL
Ollier	NULL
,	NULL
and	NULL
I.	NULL
V.	NULL
Hutchinson	NULL
.	NULL

1997	NULL
.	NULL

Genetic	NULL
variation	NULL
in	NULL
the	NULL
interleukin	NULL
10	NULL
gene	NULL
promoter	NULL
and	NULL
systemic	NULL
lupus	NULL
erythematosus	NULL
.	NULL

J.	NULL
Rheum	NULL
.	NULL

24	NULL
:	NULL
2314-2317	NULL
.	NULL

